Kerecis

Stofnun

Kerecis is an Icelandic biotechnology company that develops, manufactures, and sells patented medical products derived from sustainably sourced fish skin, primarily from Atlantic cod, for tissue regeneration and wound healing. Founded in Ísafjörður in 2010, Kerecis has gained international recognition for its innovative use of fish skin grafts to treat chronic wounds, burns, and surgical incisions, preventing amputations and promoting healing. The company's success led to its acquisition by Danish healthcare company Coloplast in 2023 for over USD 1 billion, making Kerecis Iceland's first startup unicorn. Kerecis plays a significant role in the Icelandic economy, with manufacturing and quality control in Ísafjörður and R&D and corporate functions in Reykjavík, and its operations are powered by 100% renewable energy.

Einnig þekkt sem: keresins, keresinu, Kerecis

11 tilvísanir alls2 þættir alls

Þættir í Þjóðmál

#404 – Kaffispjall – Sveinn Sölvason17. mar. 2026

Tengdar einingar

Bjarni Benediktsson3 sameiginlegar tilvísanir

Þorgerður Katrín Gunnarsdóttir3 sameiginlegar tilvísanir

Kristrún Frostadóttir3 sameiginlegar tilvísanir

Seðlabanki Íslands3 sameiginlegar tilvísanir

Ólafur Ragnar Grímsson3 sameiginlegar tilvísanir

Evrópusambandið3 sameiginlegar tilvísanir

JBT Marel5 sameiginlegar tilvísanir

Alþingi2 sameiginlegar tilvísanir

Indriði Þorláksson2 sameiginlegar tilvísanir

Róbert Guðfinnsson2 sameiginlegar tilvísanir